Vahid Saqagandomabadi

Dr. Vahid Saqagandomabadi


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
VSVahid Saqagandomabadi
Vahid Saqagandomabadi
SZSahar Sarrafzadeh Zargar
Sahar Sarrafzadeh Zargar
MPMatin Pooladi
Matin Pooladi
EAEhsan Pashay Ahi
Ehsan Pashay Ahi
Notch signaling has long been understood to be shaped by post-transcriptional regulation, yet the contribution of RNA chemical modification has only recently begun to be resolved with mechanistic clarity. In this review, an updated account of epitranscriptomic regulation of Notch signaling is provided, with emphasis placed on how RNA networks influence the processing, localization, stability, translation, and editing of transcripts encoding receptors, ligands, modulators, and downstream effectors. The available evidence is evaluated according to mechanistic strength to distinguish direct transcript-level regulation from broader pathway-associated or enrichment-based observations. Across developmental systems, stem cell states, cancer, neurological contexts, and immune or inflammatory settings, Notch activity is considered not only in terms of signaling intensity, but also through its temporal dynamics, persistence, and activation thresholds. Particular attention is given to the predominance of N6-methyladenosine (m6A)-based studies, while evidence for other RNA modifications is examined more cautiously. By integrating a fragmented and methodologically uneven body of literature, this Review proposes a framework for separating validated epitranscriptomic regulation of Notch components from correlative pathway rewiring, in order to define the experimental standards needed to strengthen mechanistic inference and translational relevance.

16 November 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
SJShayan Jalali
Shayan Jalali
MKMehran Khorshid
Mehran Khorshid
VSVahid Saqagandomabadi
Vahid Saqagandomabadi
ATAbtin Tavakoli
Abtin Tavakoli
EAEhsan Pashay Ahi
Ehsan Pashay Ahi
Transcriptome-wide differences in RNA modification-associated signals are often interpreted alongside lists of responsive sites, although the two may not be equally reproducible. We reanalysed published xPore measurements from wild-type and METTL3-knockout HEK293T cells to examine whether widespread WT–KO responses were accompanied by stable site-level rankings. From 62,222 centered-adenosine positions, we selected 1,293 DRACH sites and matched each to a non-DRACH site based on sequencing coverage and baseline knockout modification rate. Sites were ranked by WT–KO differences (contrasts) of two replicate pairs; the third contrast was examined retrospectively. Although positive WT–KO responses were common in both motif classes, site-level agreement differed markedly. After centering responses within five-nucleotide sequence contexts, Spearman correlations between the two-contrast rankings and the third contrast were 0.815 (95% CI 0.786–0.841) for DRACH sites and −0.021 for matched non-DRACH sites (−0.080 to 0.035). Among the 129 highest-ranked sites (top 10%) per contrast, 87 DRACH sites but only two non-DRACH sites appeared in all three sets. Reproducibility followed independent m6A evidence rather than the motif: GLORI-supported sites ranked reproducibly in both classes (ρ = 0.88 and 0.73), whereas unsupported non-DRACH sites did not (ρ = 0.00). Single non-DRACH contrasts had near-zero reliability, so more replicates would not stabilize their rankings, and part of the non-DRACH response also appeared between same-condition replicates. These findings show that widespread perturbation-associated responses can coexist with poor reproducibility of individual site identities, highlighting the need to evaluate aggregate signals and site-level stability separately and to prioritize reproducible, independently supported sites for follow-up.

19 November 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
NFNahal Emami Fard
Nahal Emami Fard
VSVahid Saqagandomabadi
Vahid Saqagandomabadi
EAEhsan Pashay Ahi
Ehsan Pashay Ahi
ZGZeinab Ghasemishahrestani
Zeinab Ghasemishahrestani
Some developmental and tissue-specific wounds heal with minimal fibrosis and substantial restoration of tissue structure. In this review, we examine RNA-level regulation of scarless, low-scar, and regenerative healing in fetal skin, oral mucosa, cornea, zebrafish heart, and other mammalian and fibrotic comparators. We prioritize mechanisms tested causally in vivo and distinguish these findings from associative profiling and extrapolations from normally scar-forming wounds. We focus on microRNA (miRNA) circuits that regulate inflammatory resolution, epithelial migration, fibroblast activation and persistence/exit, extracellular matrix (ECM) deposition and remodeling, and regenerative proliferation. We also assess alternative RNA processing, lncRNAs/circRNAs, RNA-binding proteins, translational control, m6A regulation, and extracellular-vesicle-mediated RNA transfer. We distinguish endogenous post-transcriptional effects from transcriptionally initiated isoform expression and exogenous RNA therapies, and identify TGF-β/SMAD signaling and collagen organization as key downstream convergence points. Across studies, extensive evidence shows that post-transcriptional regulation shapes repair processes, while substantial experimental evidence demonstrates that RNA-level interventions alter fibrosis, scarring, or regenerative responses. However, direct evidence that endogenous post-transcriptional mechanisms determine regenerative versus fibrotic outcomes remains limited. Regenerative cardiac studies implicate specific RNA-associated regulators in injury-induced proliferation and regeneration, but their mechanisms sometimes involve transcriptionally initiated isoform expression, and their effects do not necessarily determine overall repair fate. We therefore propose a phase-resolved framework linking RNA regulators to defined repair processes, tissue-level outcomes, and the strength of causal evidence for regenerative versus fibrotic trajectories.

19 May 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
LLLaurene Lecaudey
Laurene Lecaudey
ZGZeinab Ghasemishahrestani
Zeinab Ghasemishahrestani
VSVahid Saqagandomabadi
Vahid Saqagandomabadi
JWJørgen Wesche
Jørgen Wesche
EAEhsan Pashay Ahi
Ehsan Pashay Ahi
Fibroblast growth factor (FGF) signaling plays a pivotal role in the development, maintenance, and regeneration of musculoskeletal tissues. While its transcriptional regulation has been extensively characterized, accumulating evidence indicates that FGF activity is also modulated by a diverse array of post-transcriptional mechanisms. In this review, microRNAs, long non-coding RNAs, alternative splicing, and RNA modifications are examined as key regulators of FGF ligands and receptors across bone, cartilage, muscle, and tooth. Enhancer RNAs and RNA-binding proteins are also discussed as potential modulators of FGF transcript stability and translation. By integrating both established and emerging layers of RNA-level regulation, this review outlines a complex, tissue-specific architecture that fine-tunes FGF signaling in development and repair. To highlight this layered regulatory dimension, the concept of a pathway-specific RNA regulome is introduced, referring to the network of RNA-based mechanisms that modulate signaling cascades, such as FGF, across distinct biological processes. The therapeutic implications of targeting post-transcriptional nodes, particularly through non-coding RNAs and epitranscriptomic marks, are highlighted as promising avenues for future musculoskeletal interventions.